Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
National Institutes of Health · Cancer Cause and Prevention Research (93.393)
Publié 25 sept. 2026 · Environ 37 mois restants
En clair
Résumé pas encore disponible en français ; affiché en anglais.
The US National Institutes of Health funds research teams developing molecular and imaging biomarkers to detect pancreatic cancer early and identify high-risk patients. Grants up to 600,000 US dollars support multi-disciplinary research units, and applications from US-registered universities, nonprofits, governments and businesses are due by 5 November 2029.
Un résumé généré du texte du bailleur ; la formulation originale figure ci-dessous.
Résumé
Texte original du bailleur (anglais)
Through this Notice of Funding Opportunity (NOFO), NCI solicits applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC), to conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions to identify patients who are at high risk of progression to cancer. The PCDC will continue to address one of the four research priorities identified in the NCI's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma (PDAC). The PCDC will support research for the development and testing of new molecular and imaging biomarkers for detecting PDAC early and for identifying patients at high risk of PDAC (because of genetic factors, family history and/or the presence of precursor lesions) who could be candidates for early intervention. The PCDC-RUs will consist of multi-disciplinary teams and will undertake studies to: identify and test biomarkers measurable in bodily fluids for early detection of PDAC and/or its precursor lesions; develop molecular- and/or imaging-based markers of pancreatic cysts and determine which lesions are likely to progress to…
Extrait de la page du bailleur. Le texte intégral, les annexes et les formulaires se trouvent dans l'appel original.
Qui peut candidater
- Organisme public
- Établissement universitaire ou de recherche
- ONG / société civile
- Entreprise privée
Éligibilité et conditions
Afficher le texte d'éligibilité de la source · Texte original du bailleur (anglais)
Applicant types: Public and State controlled institutions of higher education; Public housing authorities/Indian housing authorities; For profit organizations other than small businesses; State governments; Special district governments; Native American tribal governments (Federally recognized); Independent school districts; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); City or township governments; Private institutions of higher education
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.